Startseite Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry

  • Magdalena Ligor , Tomasz Ligor , Amel Bajtarevic , Clemens Ager , Martin Pienz , Martin Klieber , Hubert Denz , Michael Fiegl , Wolfgang Hilbe , Wolfgang Weiss , Peter Lukas , Herbert Jamnig , Martin Hackl , Boguslaw Buszewski , Wolfram Miekisch , Jochen Schubert und Anton Amann
Veröffentlicht/Copyright: 1. Mai 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Analysis of exhaled breath is a promising diagnostic method. Sampling of exhaled breath is non-invasive and can be performed as often as considered desirable. There are indications that the concentration and presence of certain of volatile compounds in exhaled breath of lung cancer patients is different from concentrations in healthy volunteers. This might lead to a future diagnostic test for lung cancer.

Methods: Exhaled breath samples from 65 patients with different stages of lung cancer and undergoing different treatment regimes were analysed. Mixed expiratory and indoor air samples were collected. Solid phase microextraction (SPME) with carboxen/polydimethylsiloxane (CAR/PDMS) sorbent was applied. Compounds were analysed by means of gas chromatography (GC) and mass spectrometry (MS).

Results: The method we used allowed identification with the spectral library of 103 compounds showing at least 15% higher concentration in exhaled breath than in inhaled air. Among those 103 compounds, 84 were confirmed by determination of the retention time using standards based on the respective pure compound. Approximately, one third of the compounds detected were hydrocarbons. We found aromatic hydrocarbons, alcohols, aldehydes, ketones, esters, ethers, sulfur compounds, nitrogen-containing compounds and halogenated compounds. Acetonitrile and benzene were two of 10 compounds which correlated with smoking behaviour. A comparison of results from cancer patients with those of 31 healthy volunteers revealed differences in the concentration and presence of certain compounds. The sensitivity for detection of lung cancer patients based on eight different compounds not seen in exhaled breath of healthy volunteers was 51% and the specificity was 100%. These eight potential markers for detection of lung cancer are 1-propanol, 2-butanone, 3-butyn-2-ol, benzaldehyde, 2-methyl-pentane, 3-methyl-pentane, n-pentane and n-hexane.

Conclusions: SPME is a relatively insensitive method and compounds not observed in exhaled breath may be present at a concentration lower than LOD. The main achievement of the present work is the validated identification of compounds observed in exhaled breath of lung cancer patients. This identification is indispensible for future work on the biochemical sources of these compounds and their metabolic pathways.

Clin Chem Lab Med 2009;47:550–60.


Corresponding author: Anton Amann, Univ.-Clinic for Anesthesia, Anichstr 35, 6020 Innsbruck, Austria ,

Received: 2009-1-21
Accepted: 2009-3-2
Published Online: 2009-05-01
Published in Print: 2009-05-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Review
  2. Pharmacogenetics of vitamin K antagonists: useful or hype?
  3. Genetics and Molecular Diagnostics
  4. Illumina DNA test panel-based genotyping of whole genome amplified-DNA extracted from hair samples: performance and agreement with genotyping results from genomic DNA from buccal cells
  5. Association of interleukin-18 gene promoter polymorphisms with risk of acute myocardial infarction in northern Chinese Han population
  6. MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis
  7. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors
  8. Anti DNA antibodies are not restricted to a specific pattern of fluorescence on HEp2 cells
  9. General Clinical Chemistry and Laboratory Medicine
  10. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry
  11. Determination of urinary stone composition based on stone morphology: a prospective study of 325 consecutive patients in an emerging country
  12. Determination of branched chain amino acids, methionine, phenylalanine, tyrosine and α-keto acids in plasma and dried blood samples using HPLC with fluorescence detection
  13. Hematocytometry analysis as discriminative marker for asthma phenotypes
  14. A routine method for the quantification of the novel antimycotic drug posaconazole in plasma using liquid chromatography-tandem mass spectrometry
  15. Reference Values and Biological Variations
  16. Serum β2-microglobulin measured by immunonephelometry: expression patterns and reference intervals in healthy adults
  17. Serum enzyme profile characteristics of victims following the Wenchuan earthquake in China
  18. Stability of selected serum proteins after long-term storage in the Janus Serum Bank
  19. Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients
  20. Validation and Outcome Studies
  21. Workflow restrictions on hematology analyzers XE-2100 and XS-800 when assaying pediatric samples with limited volume
  22. Letters to the Editor
  23. Carbamylated hemoglobin remains a critical issue in HbA1c measurements
  24. Detection of a monoclonal gammopathy by serum index measurement
  25. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement
  26. Quantitative scanning analysis of a cryoglobulin ring detected in sera of patients with hepatitis C using a cooling gel diffusion method
  27. Significant reduction of erythrocyte glucose-6-phosphate dehydrogenase activity in soccer-players during play. Evidence for catecholamine mediated enzyme inhibition
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.133/html?lang=de
Button zum nach oben scrollen